Chemclin Diagnostics Co., Ltd.

SHSE:688468 Stock Report

Market Cap: CN¥2.6b

Chemclin Diagnostics Past Earnings Performance

Past criteria checks 2/6

Chemclin Diagnostics has been growing earnings at an average annual rate of 3%, while the Medical Equipment industry saw earnings growing at 6.5% annually. Revenues have been declining at an average rate of 2.9% per year. Chemclin Diagnostics's return on equity is 10.9%, and it has net margins of 33.1%.

Key information

3.0%

Earnings growth rate

-9.5%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate-2.9%
Return on equity10.9%
Net Margin33.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance

May 06
Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance

Recent updates

Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance

May 06
Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance

Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings

Apr 30
Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings

Chemclin Diagnostics (SHSE:688468) Shareholders Will Want The ROCE Trajectory To Continue

Mar 27
Chemclin Diagnostics (SHSE:688468) Shareholders Will Want The ROCE Trajectory To Continue

Revenue & Expenses Breakdown

How Chemclin Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688468 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2445615113967
31 Dec 2344514713365
30 Sep 2345115512864
30 Jun 2346116013468
31 Mar 2344514812967
31 Dec 2246515313568
30 Sep 2247515313670
30 Jun 2245714213668
31 Mar 2247114414271
31 Dec 2147114314367
30 Sep 2147814814959
30 Jun 2150415614864
31 Mar 2147914413958
31 Dec 2041811712954
31 Dec 1945514114155
31 Dec 18366-42463350
31 Dec 17319-43562131

Quality Earnings: 688468 has a high level of non-cash earnings.

Growing Profit Margin: 688468's current net profit margins (33.1%) are lower than last year (33.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688468 has become profitable over the past 5 years, growing earnings by 3% per year.

Accelerating Growth: 688468's earnings growth over the past year (1.7%) is below its 5-year average (3% per year).

Earnings vs Industry: 688468 earnings growth over the past year (1.7%) exceeded the Medical Equipment industry 0.09%.


Return on Equity

High ROE: 688468's Return on Equity (10.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.